AMP-activated protein kinase regulates glucagon secretion from mouse pancreatic alpha cells

Diabetologia. 2011 Jan;54(1):125-34. doi: 10.1007/s00125-010-1929-z. Epub 2010 Oct 13.

Abstract

Aim/hypothesis: AMP-activated protein kinase (AMPK), encoded by Prkaa genes, is emerging as a key regulator of overall energy homeostasis and the control of insulin secretion and action. We sought here to investigate the role of AMPK in controlling glucagon secretion from pancreatic islet alpha cells.

Methods: AMPK activity was modulated in vitro in clonal alphaTC1-9 cells and isolated mouse pancreatic islets using pharmacological agents and adenoviruses encoding constitutively active or dominant negative forms of AMPK. Glucagon secretion was measured during static incubation by radioimmunoassay. AMPK activity was assessed by both direct phosphotransfer assay and by western (immuno-)blotting of the phosphorylated AMPK α subunits and the downstream target acetyl-CoA carboxylase 1. Intracellular free [Ca²(+)] was measured using Fura-Red.

Results: Increasing glucose concentrations strongly inhibited AMPK activity in clonal pancreatic alpha cells. Forced increases in AMPK activity in alphaTC1-9 cells, achieved through the use of pharmacological agents including metformin, phenformin and A-769662, or via adenoviral transduction, resulted in stimulation of glucagon secretion at both low and high glucose concentrations, whereas AMPK inactivation inhibited both [Ca²(+)](i) increases and glucagon secretion at low glucose. Transduction of isolated mouse islets with an adenovirus encoding AMPK-CA under the control of the preproglucagon promoter increased glucagon secretion selectively at elevated glucose concentrations.

Conclusions/interpretation: AMPK is strongly regulated by glucose in pancreatic alpha cells, and increases in AMPK activity are sufficient and necessary for the stimulation of glucagon release in vitro. Modulation of AMPK activity in alpha cells may therefore provide a novel approach to controlling blood glucose concentrations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism*
  • Acetyltransferases / metabolism
  • Adenosine Triphosphate / metabolism
  • Animals
  • Blotting, Western
  • Calcium / metabolism
  • Cell Line
  • Enzyme Activation / drug effects
  • Female
  • Glucagon / metabolism*
  • Glucagon-Secreting Cells / drug effects
  • Glucagon-Secreting Cells / enzymology*
  • Glucagon-Secreting Cells / metabolism*
  • Glucose / metabolism
  • Hypoglycemic Agents / pharmacology
  • Immunohistochemistry
  • Metformin / pharmacology
  • Mice
  • Phenformin / pharmacology
  • Phosphorylation / drug effects
  • Pyrones / pharmacology
  • Thiophenes / pharmacology

Substances

  • Hypoglycemic Agents
  • Pyrones
  • Thiophenes
  • Adenosine Triphosphate
  • Glucagon
  • Metformin
  • Phenformin
  • Acetyltransferases
  • aminoglycoside N1-acetyltransferase
  • AMP-Activated Protein Kinases
  • Glucose
  • 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrile
  • Calcium